Clerio Vision Stock
Clerio Vision is developing a revolutionary product platform for the global ophthalmic market.
Sign up today and learn more about Clerio Vision Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Clerio Vision Stock
Clerio Vision is a medical device company that specializes in the fields of refractive, laser, ophthalmic, medical device, contact lenses, and intraocular lenses. The company is in process of developing and commercializing a portfolio of next-generation products in contact lenses. Clerio Vision was founded in 2014 and headquartered in Rochester, New York.
Funding History
| January 2015 | $3.7M |
|---|---|
| January 2016 | $5.0M |
| January 2016 | $270K |
| July 2017 | $5.0M |
| September 2017 | $750K |
| August 2018 | $3.0M |
| July 2019 | $11.9M |
| December 2020 | $8.3M |
| February 2021 | $12.5M |
Management
President and CCO
Trevor McCaw
CFO
Jay B. Baker
CEO
Alex Zapesochny
Board Member
David E. Williams
Founder & Chief Innovation Officer
J. Mikael Totterman
Advisor
Jeff Machat
Co-Founder, Executive vice President and Director
Alexandra Latypova
Vice Chairman & Director
Arunas Chesonis
Director
Robert Cochran
Advisor
Scott MacRae
Board Member
Brian Model
Advisor
Charles Munnerlyn
Press
patents - Apr, 15 2024
Optimized Multifocal Wavefronts for Presbyopia Correctionpatents - Apr, 15 2024
Coordinated Scanning and Power Control of Laser for Forming Structures in …patents - Apr, 15 2024
LIRIC Calibration Based on Multiphoton Excitationpatents - Apr, 15 2024
Methods and devices for chromatic aberration correctionpatents - Apr, 15 2024
Eye scopesEquityZen Recognized As:
